Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Synaptic Activity—Ubiquitination or De-ubiquitination?
8 December 2003. The ubiquitin-proteasome system, which operates in almost every eukaryotic cell, has been implicated in the pathogenesis of numerous neurodegenerative diseases, including Parkinson’s disease (PD) and Alzheimer’s (AD). So does this pathway have a specialized role in neurons?

Earlier this year, Michael Ehlers reported that synaptic activity leads to de-novo ubiquitination of proteins at the postsynaptic density (PSD), a large, specialized complex, which, through remodeling, can contribute to synaptic plasticity (scroll to Ehlers in ARF related news story); also see Ehlers, 2003). Now, in the online PNAS, Pietro De Camilli and colleagues at Yale University and the European Institute of Oncology, Milan, Italy, report data suggesting the reverse—that synaptic activity may lead to de-ubiquitination in presynaptic synaptosomes.

First author Hong Chen and colleagues examined the effect of depolarizing isolated synaptosomes with K+ and Ca2+ ions. This is thought to mimic what happens on the proximal side of a synaptic junction when an action potential reaches axonal termini. When Chen examined these depolarized synaptosomes, he found a general and dramatic reduction in the amount of ubiquitinated protein. This effect was rapid, taking as little as 15 seconds after depolarization, and it was reversible. Many proteins appeared to be de-ubiquitinated, most of them having been poly-ubiquitinated as judged by the "smeary" nature of Western blots. But some of the affected proteins, which appeared as discrete bands, seemed to have been mono-ubiquitinated. One example was Epsin 1, a protein known to be modified by the addition of only one ubiquitin peptide. The K+/Ca2+ combination resulted in a reduction of ubiquitinated Epsin.

To probe the nature of the de-ubiquitination step, Chen next looked at the role of the protein FAM, the mammalian homolog of the Drosophila protein fat facets, which is known to catalyze the de-ubiquitination of Epsin. To do this, Chen switched to HeLa cells, which are susceptible to the inhibitory action of RNAi. In these cells, ionomycin, which renders them permeable to Ca2+, also caused de-ubiquitination of many proteins including exogenous Epsin 1. Blocking expression of FAM by RNAi, however, abolished Epsin de-ubiquitination without interfering with the removal of the ubiquitin peptide from other proteins.

The data suggest that there may be general and specific de-ubiquitination events taking place at synaptosomes. These are most likely unrelated to removal of ubiquitin-tagged proteins by the proteasome, because when Chen added the general proteasome inhibitor YU101 to synaptosomes, Ca2+-induced de-ubiquitination did not change.

How calcium, in combination with potassium, achieves global de-ubiquitination is still a bit of a mystery. The authors rule out general stimulation of enzymes like FAM, instead favoring a scenario where calcium prevents ubiquitination and therefore upsets the ubiquitination/de-ubiquitination balance. Chen also shows that Ca2+-induced depolarization causes dephosphorylation of a variety of synaptosome proteins, suggesting protein phosphatases may play a role.

Reconciling the differences between their data and that of Ehlers, the authors note that pre- and postsynaptic complexes may be affected differently. An experimental difference is that Ehlers used a chronic mode of stimulation, while in the present study it was acute. Time scales may be critical, and indeed, Chen found that the de-ubiquitination is all but reversed in as little as 10 minutes.—Tom Fagan.

Reference:
Chen H, Polo S, Di Fiore PP, De Camilli PV. Rapid Ca2+-dependent decrease of protein ubiquitination at synapses. Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14908-13. Epub 2003 Dec 01. Abstract

 
Comments on News and Primary Papers
  Comment by:  Michael Ehlers
Submitted 8 December 2003  |  Permalink Posted 8 December 2003

This paper demonstrates rapid Ca2+-dependent de-ubiquitination of synaptic proteins. Using a classical biochemical preparation of synaptosomes, which are pinched-off nerve terminals with attached postsynaptic elements capable of neurotransmitter release, De Camilli and colleagues demonstrate that strong depolarization (a stimulus that triggers neurotransmitter release followed by rapid endocytosis of synaptic vesicles) causes a rapid loss of ubiquitinated proteins, likely due to "de-ubiquitination." They demonstrate that two prominent endocytic proteins—Epsin1 and Eps15—are among the proteins subject to depolarization- and Ca2+-dependent de-ubiquitination, and provide strong evidence that the enzyme that clips off ubiquitin from Epsin is the deubiquitinating enzyme fat facets/FAM. The authors perform biochemical experiments to assess what functional effect ubiquitination has on Epsin, and show that ubiquitin-conjugated Epsin is less capable of binding lipid membranes, clathrin, and AP-2—the essential molecular ingredients for synaptic vesicle endocytosis. From these data, the...  Read more
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad